P1.03. Lung Cancer Approved Tyrosine Kinase Inhibitors That Inhibit MATE-1 can Lead to “False” Decreases in Renal Function
Back to course
Pdf Summary
Asset Subtitle
Monica Chen, MSKCC, United States
Meta Tag
Speaker Monica Chen, MSKCC, United States
Topic Poster Listing
Tyrosine kinase inhibitors
lung cancer treatment
MATE inhibitors
renal function
creatinine clearance
Cystatin C
renal health
kidney injury
cancer therapy
clinical implications
Powered By